Metalloproteinases and Hypertrophic Cardiomyopathy: A Systematic Review
Sign Up to like & getrecommendations! Published in 2023 at "Biomolecules"
DOI: 10.3390/biom13040665
Abstract: Hypertrophic cardiomyopathy (HCM) is a genetic condition determined by an altered collagen turnover of the extracellular matrix. Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are abnormally released in patients with HCM. The purpose of this… read more here.
Keywords: cardiomyopathy systematic; hypertrophic cardiomyopathy; metalloproteinases hypertrophic; systematic review ... See more keywords